SaveHealth reports on managing type 2 diabetes through medications, lifestyle changes, and support, highlighting various ...

Groundbreaking research reveals that common blood sugar medications do more than manage glucose—they are actively reshaping ...

The rising demand for obesity drugs is prompting Indian pharma firms to pursue licensing and distribution partnerships, ...

Lupin has signed the agreement with China-based Gan & Lee Pharmaceuticals for Bofanglutide. With this, it gets exclusive ...

Lupin signed an exclusive licensing, supply and distribution pact with China's Gan & Lee for Bofanglutide, a fortnightly ...

The agreement is aimed at strengthening Lupin’s diabetes portfolio and expanding its presence in the obesity segment.

Vanda Pharmaceuticals said on Tuesday its drug for the prevention of motion-induced vomiting was approved by the U.S. health ...

Beginning in January 2026, this pill - developed by Danish pharmaceutical company Novo Nordisk - will become a daily option ...

At least 12% of adults in the U.S. have been prescribed a glucagon‐like peptide‐1 drug for one or multiple indications, but ...

A rare form of diabetes is emerging in the very first weeks of life, reshaping how doctors think about blood sugar disorders ...

Oprah Winfrey candidly detailed her health and weight loss journey since starting GLP-1 medication, noting she can “hardly ...